HHLR ADVISORS, LTD. filings

This page lists the SEC filings reported by HHLR ADVISORS, LTD..

SEC filings by HHLR ADVISORS, LTD. (ownership)
TypeFiledFilerSubjectShares OwnedPercent Owned
SC 13G/A2024-02-14HHLR ADVISORS, LTD.Agora, Inc.19,287,3005.1%EDGAR
SC 13G/A2024-02-14HHLR ADVISORS, LTD.Bright Scholar Education Holdings Ltd3,952,57212.6%EDGAR
SC 13G/A2024-02-14HHLR ADVISORS, LTD.MOGU Inc.254,253,00511.8%EDGAR
SC 13G/A2024-02-14HHLR ADVISORS, LTD.Aligos Therapeutics, Inc.5,971,4268.2%EDGAR
SC 13G/A2024-02-14HHLR ADVISORS, LTD.Cytek Biosciences, Inc.6,657,0304.9%EDGAR
SC 13G/A2024-02-14HHLR ADVISORS, LTD.Kiniksa Pharmaceuticals, Ltd.3,879,4269.9%EDGAR
SC 13G/A2024-02-14HHLR ADVISORS, LTD.Smart Share Global Ltd62,367,29314.0%EDGAR
SC 13G/A2023-08-18HHLR ADVISORS, LTD.Kiniksa Pharmaceuticals, Ltd.3,541,3019.9%EDGAR
SC 13D/A2023-06-30HHLR ADVISORS, LTD.I-Mab15,891,2118.3%EDGAR
SC 13D/A2023-02-14HHLR ADVISORS, LTD.BeiGene, Ltd.147,043,05810.9%EDGAR
SC 13G/A2023-02-14HHLR ADVISORS, LTD.Yatsen Holding Ltd300,560,60219.1%EDGAR
SC 13G/A2023-02-14HHLR ADVISORS, LTD.Bright Scholar Education Holdings Ltd3,985,79615.6%EDGAR
SC 13G/A2023-02-14HHLR ADVISORS, LTD.MOGU Inc.261,174,00511.9%EDGAR
SC 13G/A2023-02-14HHLR ADVISORS, LTD.Kiniksa Pharmaceuticals, Ltd.2,623,9247.6%EDGAR
SC 13G/A2023-02-14HHLR ADVISORS, LTD.Gossamer Bio, Inc.4,974,0415.3%EDGAR
SC 13G/A2023-02-14HHLR ADVISORS, LTD.Cytek Biosciences, Inc.8,684,5306.4%EDGAR
SC 13G/A2023-02-14HHLR ADVISORS, LTD.Aligos Therapeutics, Inc.2,309,7645.8%EDGAR
SC 13G/A2023-02-14HHLR ADVISORS, LTD.Root, Inc.138,9771.5%EDGAR
SC 13G/A2023-02-14HHLR ADVISORS, LTD.On Holding AG5,468,5041.9%EDGAR
SC 13D/A2022-08-16HHLR ADVISORS, LTD.BeiGene, Ltd.147,035,25810.9%EDGAR
Form 13F-HR
The 13F-HR report is filed quarterly to report securities held by the filer that fall under the SEC's 13F rules.
Form SC 13D/G
Reported by persons and groups who own 5% or more of any class of a company's outstanding shares. If the ownership changes by 1% or more, an amendment must be filed.
Form 3, 4, and 5
Form 3, 4, and 5 reports are filed to report insider transactions by company officers and directors, and any beneficial owners of more than ten percent of a company's shares. Form 3 is the initial report that must be filed when a person becomes an officer, director, or beneficial owner. Form 4 reports are used to report changes in ownership, while the Form 5 report is used for reporting transactions that should have been reported earlier in a Form 4 filing.